1. Pharmacological Mechanism of Danggui-Sini Formula for Intervertebral Disc Degeneration: A Network Pharmacology Study
   Longjie Wang et al, 2021, BioMed Research International CrossRef
2. IL‐17 in intervertebral disc degeneration: Mechanistic insights and therapeutic implications
   Jing‐Hua Tan et al, 2022, Cell Biology International CrossRef
3. The Role of IL-17-Mediated Inflammatory Processes in the Pathogenesis of Intervertebral Disc Degeneration and Herniation: A Comprehensive Review
   Kaori Suyama et al, 2022, Frontiers in Cell and Developmental Biology CrossRef
4. Research on the role and mechanism of IL-17 in intervertebral disc degeneration
   Bing Peng et al, 2024, International Immunopharmacology CrossRef
5. The role of structure and function changes of sensory nervous system in intervertebral disc-related low back pain
   S. Zhang et al, 2021, Osteoarthritis and Cartilage CrossRef
6. The role of TNF-α in osteoporosis, bone repair and inflammatory bone diseases: A review
   Qingshuang Yao et al, 2024, Tissue and Cell CrossRef
7. Herbal Formula Modified Bu-Shen-Huo-Xue Decoction Attenuates Intervertebral Disc Degeneration via Regulating Inflammation and Oxidative Stress
   Jialiang Lin et al, 2022, Evidence-Based Complementary and Alternative Medicine CrossRef
8. Low back pain scores correlate with the cytokine mRNA level in lumbar disc biopsies: a study of inflammatory markers in patients undergoing lumbar spinal fusion
   Sanjay S. Aripaka et al, 2021, European Spine Journal CrossRef
9. A structured biomimetic nanoparticle as inflammatory factor sponge and autophagy-regulatory agent against intervertebral disc degeneration and discogenic pain
   Kanglu Li et al, 2024, Journal of Nanobiotechnology CrossRef
10. Yiqi Huoxue Recipe alleviates intervertebral disc degeneration by suppressing interleukin-17, nucleus pulposus cell apoptosis and promoting SOX9/β-catenin pathway
    Zhijia MA et al, 2022, Food Science and Technology CrossRef
11. Inactivation of Tnf‐α/Tnfr signaling attenuates progression of intervertebral disc degeneration in mice
    Chu Tao et al, 2024, JOR SPINE CrossRef
12. PPAR-γ agonist pioglitazone protects against IL-17 induced intervertebral disc inflammation and degeneration via suppression of NF-κB signaling pathway
    Yi Liu et al, 2019, International Immunopharmacology CrossRef
13. Network Pharmacology with Metabolomics Study to Reveal the Mechanisms of Bushen Huoxue Formula in Intervertebral Disc Degeneration Treatment
    Ji Guo et al, 2024, Drug Design, Development and Therapy CrossRef
14. Carthamin yellow inhibits matrix degradation and inflammation induced by LPS in the intervertebral disc via suppression of MAPK pathway activation
    Bin Chen et al, 2017, Experimental and Therapeutic Medicine CrossRef
15. Immunomodulation of mesenchymal stem cells in discogenic pain
    Laura Miguélez-Rivera et al, 2018, The Spine Journal CrossRef
16. An in vivo study of the effect of c-Jun on intervertebral disc degeneration in rats
    Ming Lei et al, 2021, Bioengineered CrossRef
17. The mechanisms and functions of TNF-α in intervertebral disc degeneration
    Hongyu Pan et al, 2023, Experimental Gerontology CrossRef
18. Expression of MIF and TNFA in psoriatic arthritis: relationship with Th1/Th2/Th17 cytokine profiles and clinical variables
    L. A. Bautista-Herrera et al, 2018, Clinical and Experimental Medicine CrossRef
19. The role of IL-1β and TNF-α in intervertebral disc degeneration
    Yongjie Wang et al, 2020, Biomedicine & Pharmacotherapy CrossRef